These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 30309639)

  • 21. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT
    Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
    Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
    Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
    Onal C; Guler OC; Yildirim BA
    Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Joo JH; Park JH; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Park J; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):876-883. PubMed ID: 29063852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.
    Chmura S; Winter KA; Robinson C; Pisansky TM; Borges V; Al-Hallaq H; Matuszak M; Park SS; Yi S; Hasan Y; Bazan J; Wong P; Yoon HA; Horton J; Gan G; Milano MT; Sigurdson ER; Moughan J; Salama JK; White J
    JAMA Oncol; 2021 Jun; 7(6):845-852. PubMed ID: 33885704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Juan O; Popat S
    Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
    Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.
    Scorsetti M; Clerici E; Navarria P; D'Agostino G; Piergallini L; De Rose F; Ascolese A; Tozzi A; Iftode C; Villa E; Comito T; Franzese C; Mancosu P; Tomatis S; Cozzi L
    Br J Radiol; 2015 Sep; 88(1053):20150111. PubMed ID: 26183933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art].
    De Bari B; Guillet M; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):72-6. PubMed ID: 21216647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Huynh MA; Tang C; Siva S; Berlin A; Hannan R; Warner A; Koontz B; De Meeleer G; Palma D; Ost P; Tran PT
    Eur Urol Oncol; 2023 Feb; 6(1):28-38. PubMed ID: 36283936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
    Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
    Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
    Wang WJ; Chiou JF; Huang Y
    J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
    Ahmed KA; Torres-Roca JF
    Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligometastatic Disease and Local Therapies: A Medical Oncology Perspective.
    Hafez N; Gettinger S
    Cancer J; 2020; 26(2):144-148. PubMed ID: 32205539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of oligometastatic or oligoprogression cancer].
    Bourgier C; Latorzeff I; Fenoglietto P; Boisselier P; Charissoux M; Llacer C; Lemanski C; Riou O; Farcy-Jacquet MP; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):482-485. PubMed ID: 31495737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiation therapy for colorectal cancer liver metastases; early results.
    Burkon P; Slampa P; Kazda T; Slavik M; Prochazka T; Vrzal M
    Klin Onkol; 2012; 25 Suppl 2():2S93-7. PubMed ID: 23581024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
    Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
    Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.